Bank of Montreal’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-945,516
| Closed | -$6.32M | – | 4137 |
|
|
2023
Q1 | $6.32M | Sell |
945,516
-761,878
| -45% | -$5.26M | ﹤0.01% | 1131 |
|
|
2022
Q4 | $10.9M | Buy |
1,707,394
+1,029,815
| +152% | +$8.04M | ﹤0.01% | 949 |
|
|
2022
Q3 | $6.69K | Buy |
+677,579
| New | +$7.81M | ﹤0.01% | 1196 |
|
|
2022
Q2 | – | Sell |
-229,734
| Closed | -$3.84M | – | 4253 |
|
|
2022
Q1 | $3.84M | Buy |
229,734
+100,671
| +78% | +$1.56M | ﹤0.01% | 1601 |
|
|
2021
Q4 | $2.51M | Buy |
+129,063
| New | +$2.84M | ﹤0.01% | 1488 |
|
|
2021
Q3 | – | Sell |
-134,046
| Closed | -$3.55M | – | 3879 |
|
|
2021
Q2 | $3.55M | Buy |
134,046
+129,751
| +3,021% | +$3.37M | ﹤0.01% | 1775 |
|
|
2021
Q1 | $135K | Buy |
4,295
+994
| +30% | +$41.2K | ﹤0.01% | 3265 |
|
|
2020
Q4 | $169K | Buy |
3,301
+1,353
| +69% | +$53.7K | ﹤0.01% | 3319 |
|
|
2020
Q3 | $55K | Buy |
1,948
+15
| +0.8% | +$460 | ﹤0.01% | 3387 |
|
|
2020
Q2 | $59K | Sell |
1,933
-6,380
| -77% | -$210K | ﹤0.01% | 3354 |
|
|
2020
Q1 | $240K | Sell |
8,313
-7,319
| -47% | -$194K | ﹤0.01% | 2262 |
|
|
2019
Q4 | $432K | Buy |
15,632
+3,238
| +26% | +$73.7K | ﹤0.01% | 2757 |
|
|
2019
Q3 | $225K | Buy |
12,394
+457
| +4% | +$10.1K | ﹤0.01% | 2831 |
|
|
2019
Q2 | $293K | Buy |
11,937
+9,599
| +411% | +$145K | ﹤0.01% | 2722 |
|
|
2019
Q1 | $22K | Sell |
2,338
-1,495
| -39% | -$14.5K | ﹤0.01% | 3643 |
|
|
2018
Q4 | $33K | Buy |
3,833
+928
| +32% | +$8.95K | ﹤0.01% | 3451 |
|
|
2018
Q3 | $32K | Sell |
2,905
-1,017
| -26% | -$14.4K | ﹤0.01% | 3555 |
|
|
2018
Q2 | $50K | Buy |
3,922
+584
| +17% | +$8.54K | ﹤0.01% | 3404 |
|
|
2018
Q1 | $56K | Buy |
3,338
+2,500
| +298% | +$37.9K | ﹤0.01% | 3190 |
|
|
2017
Q4 | $7K | Sell |
838
-525
| -39% | -$4.21K | ﹤0.01% | 3872 |
|
|
2017
Q3 | $11K | Buy |
1,363
+525
| +63% | +$3.32K | ﹤0.01% | 3666 |
|
|
2017
Q2 | $6K | Buy |
838
+742
| +773% | +$4.72K | ﹤0.01% | 3835 |
|
|
2017
Q1 | $1K | Hold |
96
| – | – | ﹤0.01% | 3888 |
|
|
2016
Q4 | $1K | Sell |
96
-18,584
| -99% | -$128K | ﹤0.01% | 3966 |
|
|
2016
Q3 | $154K | Hold |
18,680
| – | – | ﹤0.01% | 2556 |
|
|
2016
Q2 | $151K | Buy |
18,680
+18,484
| +9,431% | +$116K | ﹤0.01% | 2615 |
|
|
2016
Q1 | $1K | Sell |
196
-13,506
| -99% | -$73.9K | ﹤0.01% | 4069 |
|
|
2015
Q4 | $106K | Buy |
+13,702
| New | +$95.1K | ﹤0.01% | 2751 |
|
Other funds holding IOVA
PA
MFM
ACA
PAMS
O
Bank of Montreal's IOVA Position: Q2 2023 in Review
Bank of Montreal sold out of Iovance Biotherapeutics (IOVA) in Q2 2023, closing a stake of 945,516 shares — an estimated $6.32M sold.
Bank of Montreal first reported a position in IOVA in Q4 2015 and held it in 28 quarters. The position peaked at $10.9M in Q4 2022. 219 funds tracked by Wall St. Rank hold IOVA as of Q2 2023.
- Bank of Montreal reported no remaining Iovance Biotherapeutics position as of Q2 2023 after selling out during the quarter.
- Bank of Montreal sold 945,516 Iovance Biotherapeutics shares in Q2 2023, an estimated $6.32M.
- Bank of Montreal first reported a position in Iovance Biotherapeutics in Q4 2015 and held it in 28 quarters.
- Bank of Montreal's Iovance Biotherapeutics position peaked at $10.9M in Q4 2022.
- 219 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2023.
Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.